含RGD配体在靶向细胞整合素中的作用：卵巢癌病毒疗法的应用（综述）
Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).
作者信息
Gamble Lena J, Borovjagin Anton V, Matthews Qiana L
机构信息
Division of Human Gene Therapy, Departments of Medicine, Pathology, Surgery, Obstetrics and Gynecology, The Gene Therapy Center, Birmingham, AL, USA.
出版信息
Exp Ther Med. 2010 Mar;1(2):233-240. doi: 10.3892/etm_00000037.
Abstract
The purpose of this article was to review the current strategies of targeted therapy to integrins and define the best course of future research in ovarian cancer targeting. Cell surface integrin targeting has been used as a strategy for targeted therapy of several diseases with some success. The combination of virotherapy and integrin-targeting shows promise as a method for targeting ovarian cancer. More specifically, targeting of ovarian cancer with integrin-directed adenoviruses may lead to therapy with fewer toxicities and side effects. This article offers a review of the benefits of integrin-specific targeted therapy for several diseases and proposes a unique anti-ovarian cancer strategy involving the combination of the above with virotherapy as a potential anti-ovarian cancer treatment.
摘要
本文旨在综述目前针对整合素的靶向治疗策略，并确定未来卵巢癌靶向研究的最佳方向。细胞表面整合素靶向已被用作几种疾病靶向治疗的策略，并取得了一定成功。病毒疗法与整合素靶向相结合显示出作为一种靶向卵巢癌方法的前景。更具体地说，用整合素导向腺病毒靶向卵巢癌可能会带来毒性和副作用更少的治疗效果。本文综述了整合素特异性靶向治疗对几种疾病的益处，并提出了一种独特的抗卵巢癌策略，即将上述方法与病毒疗法相结合，作为一种潜在的抗卵巢癌治疗手段。
相似文献
1
Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).含RGD配体在靶向细胞整合素中的作用：卵巢癌病毒疗法的应用（综述）
Exp Ther Med. 2010 Mar;1(2):233-240. doi: 10.3892/etm_00000037.
2
Role of RGD-binding Integrins in ovarian cancer progression, metastasis and response to therapy.RGD结合整合素在卵巢癌进展、转移及治疗反应中的作用
Integr Biol (Camb). 2025 Jan 8;17. doi: 10.1093/intbio/zyaf003.
3
Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy.癌症纳米医学中整合素的靶向作用：在癌症诊断与治疗中的应用
Cancers (Basel). 2019 Nov 13;11(11):1783. doi: 10.3390/cancers11111783.
4
Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.整合素抑制剂治疗卵巢癌的潜力：文献综述
Cancers (Basel). 2017 Jul 8;9(7):83. doi: 10.3390/cancers9070083.
5
Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd).用新型双靶点条件性复制腺病毒（CRAd）治疗卵巢癌。
Gynecol Oncol. 2007 Apr;105(1):113-21. doi: 10.1016/j.ygyno.2006.10.057. Epub 2006 Dec 14.
6
MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity.微小RNA可通过失调整合素活性影响卵巢癌进展。
Cancers (Basel). 2023 Sep 8;15(18):4449. doi: 10.3390/cancers15184449.
7
Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.用于卵巢癌治疗的假型αvβ6整合素靶向腺病毒载体
Oncotarget. 2016 May 10;7(19):27926-37. doi: 10.18632/oncotarget.8545.
8
Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting.靶向识别RGD的整合素：药物研发、生物材料研究、肿瘤成像与靶向治疗
Curr Pharm Des. 2006;12(22):2723-47. doi: 10.2174/138161206777947740.
9
Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine-Glycine-Aspartate) Strategies.整合素靶向及其他：采用双靶向RGD（精氨酸-甘氨酸-天冬氨酸）策略增强癌症治疗效果
Pharmaceuticals (Basel). 2024 Nov 20;17(11):1556. doi: 10.3390/ph17111556.
引用本文的文献
1
The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer.p53 靶向治疗在卵巢癌中的挑战与展望。
Biomolecules. 2023 Jan 12;13(1):159. doi: 10.3390/biom13010159.
2
Engineering and Validation of a Peptide-Stabilized Poly(lactic--glycolic) Acid Nanoparticle for Targeted Delivery of a Vascular Disruptive Agent in Cancer Therapy.工程与验证肽稳定的聚乳酸-共-羟基乙酸纳米粒用于癌症治疗中血管破坏剂的靶向递送。
Bioconjug Chem. 2022 Dec 21;33(12):2348-2360. doi: 10.1021/acs.bioconjchem.2c00418. Epub 2022 Nov 11.
3
Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.载吉西他滨的RGD修饰脂质体用于卵巢癌：制备、表征及药效学研究
Drug Des Devel Ther. 2019 Sep 17;13:3281-3290. doi: 10.2147/DDDT.S211168. eCollection 2019.
4
Design of an Amphiphilic Poly(aspartamide)-mediated Self-assembled Nanoconstruct for Long-Term Tumor Targeting and Bioimaging.设计一种两亲性聚（天冬酰胺）介导的自组装纳米构建体用于长期肿瘤靶向和生物成像。
Molecules. 2019 Mar 2;24(5):885. doi: 10.3390/molecules24050885.
5
Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma.系统替莫唑胺激活噬菌体靶向基因治疗在人类脑胶质瘤中的疗效。
EMBO Mol Med. 2019 Apr;11(4). doi: 10.15252/emmm.201708492.
6
Integrin β1 regulates the invasion and radioresistance of laryngeal cancer cells by targeting CD147.整合素β1通过靶向CD147调节喉癌细胞的侵袭和放射抗性。
Cancer Cell Int. 2018 Jun 7;18:80. doi: 10.1186/s12935-018-0578-z. eCollection 2018.
7
A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors.一种使用罕见腺病毒血清型48载体的新型恰加斯病疫苗方法。
Viruses. 2016 Mar 10;8(3):78. doi: 10.3390/v8030078.
8
Angiogenesis in cancer: Anti-VEGF escape mechanisms.癌症中的血管生成：抗 VEGF 逃逸机制。
Transl Lung Cancer Res. 2012 Mar;1(1):14-25. doi: 10.3978/j.issn.2218-6751.2011.11.02.
9
In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancer.含格尔德霉素和多西他赛的HPMA共聚物-RGDfK缀合物对卵巢癌的体外协同作用
Macromol Biosci. 2014 Dec;14(12):1735-47. doi: 10.1002/mabi.201400360. Epub 2014 Sep 4.
本文引用的文献
1
The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation.丝裂原活化蛋白激酶激活的蛋白激酶 2 在系统性和皮肤炎症的 p38/TNF-α通路中的作用。
J Invest Dermatol. 2010 Feb;130(2):481-91. doi: 10.1038/jid.2009.218. Epub 2009 Aug 6.
2
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.凝血因子X在局部的表达增加会导致人和小鼠肺损伤中的纤维化反应。
J Clin Invest. 2009 Sep;119(9):2550-63. doi: 10.1172/JCI33288. Epub 2009 Aug 3.
3
The biology of ovarian cancer: new opportunities for translation.卵巢癌生物学：转化医学的新机遇
Nat Rev Cancer. 2009 Jun;9(6):415-28. doi: 10.1038/nrc2644.
4
Oncolytic adenoviral gene therapy in ovarian cancer: why we are not wasting our time.溶瘤腺病毒基因疗法治疗卵巢癌：我们为何没有白费力气。
Future Oncol. 2009 Apr;5(3):339-57. doi: 10.2217/fon.09.11.
5
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.卵巢癌中对αvβ3整合素抗体介导靶向的肿瘤选择性反应。
Neoplasia. 2008 Nov;10(11):1259-67. doi: 10.1593/neo.08740.
6
Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.在MDA-MB-435异种移植小鼠模型中，使用靶向α5β1（ανβ3）的治疗诊断纳米颗粒进行血管生成的三维磁共振成像。
FASEB J. 2008 Dec;22(12):4179-89. doi: 10.1096/fj.08-112060. Epub 2008 Aug 12.
7
The current status of adenovirus-based cancer gene therapy.基于腺病毒的癌症基因治疗的现状
Mol Cells. 2008 Jun 30;25(4):462-6. Epub 2008 May 6.
8
ANTI-ADHESION evolves to a promising therapeutic concept in oncology.抗粘连已发展成为肿瘤学中一个有前景的治疗理念。
Curr Med Chem. 2008;15(10):978-90. doi: 10.2174/092986708784049667.
9
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo.腺病毒5型六邻体蛋白对于病毒在体内感染肝细胞至关重要。
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5483-8. doi: 10.1073/pnas.0711757105. Epub 2008 Apr 7.
10
Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001.卵巢癌的条件生存：1988 - 2001年监测、流行病学和最终结果（SEER）数据集的结果
Gynecol Oncol. 2008 May;109(2):203-9. doi: 10.1016/j.ygyno.2008.01.033. Epub 2008 Mar 7.
Zotero 插件